MIRM financials
Mirum Pharmaceuticals (MIRM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MIRM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $521.31M | $420.73M | -$22.14M | -$23.36M | -0.47 |
| 2024 | $336.89M | $255.25M | -$87.61M | -$87.94M | -1.85 |
| 2023 | $186.37M | $139.34M | -$109.15M | -$163.41M | -4.00 |
| 2022 | $77.06M | $64.69M | -$131.22M | -$135.66M | -4.02 |
| 2021 | $19.14M | $17.23M | -$173.41M | -$83.99M | -2.77 |
| 2020 | $0.00 | -$623.00K | -$104.30M | -$103.27M | -4.09 |
- MIRM revenue was $521.31M in fiscal 2025, net income -$23.36M.
Updated 2026-11-03 02:05 UTC